Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

Abstract Background We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. Method We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial with pragmatic considerations assessing the safety and efficacy of Fakhravac and BBIBP-Corv2 vaccines. We started...

Full description

Bibliographic Details
Main Authors: Masoud Solaymani-Dodaran, Pouria Basiri, Milad Moradi, Kimiya Gohari, Ali Sheidaei, Mohammadreza Ahi, Farzad Ghafoori Naeeni, Akram Ansarifar, Zahra Rahimi, Fatemeh Gholami, Ahmad Karimi Rahjerdi, Ramin Hamidi Farahani, Kosar Naderi saffar, Soheil Ghasemi, Ali Shooshtari, Mohsen Honari, Ali Mozafari, Samane Khodaverdloo, Mohsen Forooghizadeh
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Virology Journal
Subjects:
Inactivated Covid-19 vaccine
Phase III non-inferiority trial
Fakhravac
BBIBP-Corv2
Online Access:https://doi.org/10.1186/s12985-023-02121-z

Internet

https://doi.org/10.1186/s12985-023-02121-z

Similar Items